The Symposium

About the Symposium

Drug discovery identifies potential new therapeutic entities using computational, experimental, translational, and clinical models. Despite advances in biotechnology and understanding of biological systems, drug discovery is still lengthy, costly, and difficult with a high attrition rate of new therapeutic discovery. A complete drug discovery business process typically involves four phases: Early Drug Discovery, Pre-Clinical Phase, Clinical Phases, and Regulatory Approval.

The First Cannabinoid Translational Science Symposium aims to strengthen connections between all the actors of the drug discovery process in the cannabinoid field. Experts who design the new chemical entities will be brought into contact with experts who validate the therapeutic potential of such molecules at the pre-clinical or clinical levels and specialists in regulatory affairs who deal with organization adherence to regulatory compliance.

To favor productive dialogs between all stakeholders, at the end of each scientific session, all speakers will participate in chaired panel discussions to foster and translate cannabinoid science into practice.

Why a cannabinoid translational science symposium?

Cannabinoids are molecules acting on a tightly regulated and complex system (the endocannabinoid system), which represent a promising therapeutic strategy for a plethora of treatments. Despite the enormous progress and knowledge of devoted research and technological advances to date achieved, the exploitation of the cannabinoid therapeutical potential is not at its maximum yet. Translating a scientific discovery from the laboratory to human application involves a series of challenges. We do believe that fostering communication between the key stakeholders is a mandatory action needed to succeed in such a goal.

The Cannabinoid Translational Science symposium aims at gathering a diverse range of speakers and discussion leaders from different institutions, organizations, and industries worldwide and it is mainly focused on strengthening a bridge between companies and academics working in the cannabinoid field.

Chairs:

Alessia Ligresti and Marialessandra Contino

Scientific committee:

Carmen Abate (UniBA), Angela Stefanachi (UniBa), Giuseppe Mangiatordi (CNR), Fabiana Piscitelli (CNR)

Organizing committee:

Daniela Esposito (CNR), Giovanni Graziano (UniBA)

Editions and Promotions

Registrations are now officially open!

The first edition of the Cannabinoid Translational Science Symposium will be held remotely
on February 2025, Monday 10^th, Monday 17^th, and Monday 24^th.

Each day a different theme will be deepened:

• Neuroinflammation
• Oncology and Pain
• Trials for Therapeutic and Drug Development Purposes

Become a sponsor

The Cannabinoid Translational Science Symposium will foster collaboration among researchers, healthcare professionals, and industry leaders dedicated to advancing the understanding and application of cannabinoids in various therapeutic contexts.

WHY SHOULD YOU BECOME A SPONSOR?!

• Visibility: As a sponsor, your brand will gain significant exposure to a diverse audience of researchers, clinicians, and industry stakeholders.
• Networking Opportunities: Connect with key decision-makers and thought leaders in the field, facilitating valuable partnerships and collaborations.
• Showcase Your Commitment: Demonstrate your organization’s commitment to advancing cannabinoid research and its applications in healthcare.

TYPES OF SPONSORSHIP

• Silver Sponsorship: Support a single session of the symposium, which includes visibility during the welcome address and speakers’ introductions.
• Gold Sponsorship: Elevate your presence by sponsoring all sessions of the symposium. This package includes recognition during the welcome address and speakers’ introductions, as well as your logo on the symposium’s default slide layout.
• Platinum Sponsorship: Maximize your exposure by sponsoring all sessions of the symposium. This premium package includes recognition during the welcome address and speakers’ introductions, your logo on the symposium’s default slide layout, placement of your logo on the event website, promotional coverage during the symposium’s marketing campaign, and dynamic advertisements during event transitions.

For dynamic advertisements, sponsors are requested to provide animation with transparency as File Type: .mov with Alpha channel Format: 16:9 Minimum Resolution: 1920 x 1080. Basic animation can be created by our experts using the logo provided by the sponsor in high resolution or vector format for an additional fee of €60.
Note: Due to the limited number of transitions available during the event, a first-come, first-served policy will apply.

For more information write to ctscannabinoids@gmail.com

Our Sponsors

Gold sponsors

Supported by